Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner Search Turns To Alternates: Ex-Merck Exec Added To List

Executive Summary

One of the alternate FDA commissioner candidates under consideration by the Bush Administration is geneticist and former Merck R&D exec Thomas Caskey, MD.

You may also be interested in...



GSK Has Generalized Anxiety For Paxil, Augmented Patent For Augmentin

GlaxoSmithKline is initiating direct-to-consumer advertising to support Paxil for generalized anxiety disorder to coincide with the market entrance of the first generic versions of Prozac.

Celebrex Growth Is "Typical" Of NSAIDs After Three Years, Pharmacia Says

Pharmacia's Celebrex is showing a growth curve that is typical for products in the non-steroidal anti-inflammatory class, CEO Fred Hassan acknowledged during a July 25 analysts call.

Medicare Rx Subsidies Could Be Partially Covered By States - Sen. Graham

Medicare drug program premiums could be lowered through joint federal/state funding of subsidies for low-income beneficiaries, Sen. Graham (D-Fla.) told a press briefing July 18.

Related Content

UsernamePublicRestriction

Register

PS038246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel